Blacks, Hispanics and Asians are more likely than whites to spend their life savings to extend life; preferences could inform cancer care.

By mapping a patient’s genome, and their tumor’s, with whole-genome sequencing, physicians can use more targeted therapies.

Tigatuzumab, developed at UAB with Daiichi-Sankyo, targets aggressive, hard-to-treat tumors that make up 25 percent of all breast cancers

UAB Comprehensive Cancer Center helps drop cancer disparities while brain tumor research holds promise for new therapies to fight gliomas

NASA-developed technology designed to grow plants in space proves effective at treating cancer patients’ mouth sores in a UAB clinical trial.